Effect of Antibiotic De-Escalation on Clinical Outcomes in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia (CRE) in the Hematology-Oncology Setting
Abstract
Share and Cite
Bansal, N.; Sachdeva, N.; Bhurani, D.; Agarwal, N.; Ahmed, R.; Mehta, P.; Halder, R. Effect of Antibiotic De-Escalation on Clinical Outcomes in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia (CRE) in the Hematology-Oncology Setting. GERMS 2023, 13, 221-228. https://doi.org/10.18683/germs.2023.1388
Bansal N, Sachdeva N, Bhurani D, Agarwal N, Ahmed R, Mehta P, Halder R. Effect of Antibiotic De-Escalation on Clinical Outcomes in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia (CRE) in the Hematology-Oncology Setting. GERMS. 2023; 13(3):221-228. https://doi.org/10.18683/germs.2023.1388
Chicago/Turabian StyleBansal, Nitin, Neelam Sachdeva, Dinesh Bhurani, Narendra Agarwal, Rayaz Ahmed, Pallavi Mehta, and Rohan Halder. 2023. "Effect of Antibiotic De-Escalation on Clinical Outcomes in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia (CRE) in the Hematology-Oncology Setting" GERMS 13, no. 3: 221-228. https://doi.org/10.18683/germs.2023.1388
APA StyleBansal, N., Sachdeva, N., Bhurani, D., Agarwal, N., Ahmed, R., Mehta, P., & Halder, R. (2023). Effect of Antibiotic De-Escalation on Clinical Outcomes in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia (CRE) in the Hematology-Oncology Setting. GERMS, 13(3), 221-228. https://doi.org/10.18683/germs.2023.1388